12 news items
Atossa Therapeutics Announces Support Of New Breast Cancer Screening Guidelines
ATOS
7 May 24
screening starting at age 40. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
, Pfizer. "We are proud to continue our legacy of developing innovative treatment options for people impacted by metastatic breast cancer and look
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
, Pfizer. "We are proud to continue our legacy of developing innovative treatment options for people impacted by metastatic breast cancer
Atossa Therapeutics Announces Expanded Research Agreement With Weill Cornell Medicine To Further Evaluate Synergy Between Antibody Drug Conjugates And (Z)-Endoxifen
ATOS
29 Apr 24
)-endoxifen. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology
Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
ATOS
29 Apr 24
(ADCs) and (Z)-endoxifen. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need
5psu33ntaftmudav
ATOS
15 Apr 24
with ER+/HER2- breast cancer. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet
wb1wl3wm3c7q6f6l1x9mjeeeipbs9jzybb4
ATOS
11 Apr 24
for one-on-one meetings with registered investors of the conference. Atossa is a clinical stage biopharmaceutical company developing innovative
f8wyqbh2fop0f128 imyrhctfnrfx1frm2ry0iejm706z1
ATOS
9 Apr 24
innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
13l3lqqff3x86p4gqr0kt7qg8umq8u0xv mw9jzb3evs
ATOS
9 Apr 24
innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. The data, which is being
vghaafcyfekzlhzdfzghw51ubh7wig6ihyu mfgt50zw9vxqf7lq
ATOS
1 Apr 24
stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology with a focus on breast
wzj5wbbs033xcgp7q6ovc2za2dclhwc8n
ATOS
12 Mar 24
" or the "Company"), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus
0f87xfhn1hu1l1i jufayujumdvxy
ATOS
22 Feb 24
biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today
- Prev
- 1
- Next